___

• 1-Kahn SE, Prigeon RL, Schwartz RS, et al. Obesity, body fat distribution, insulin sensitivity and Islet beta-cell function as explanations for metabolic diversity. J Nutr 2001; 131: 354-360
• 2-Songer TJ, Zimmet PZ, Epidemiology of type II diabetes: an international perspective. Pharmacoeconomics 1995; 8: 1-11
• 3-Hardy E, Jabbour SA, Thiazoldinediones. Textbook of type 2 diabetes mellitus. Goldstein BJ, Müler-Wieland D (eds). 1.baskı. İstanbul: Düzey Matbaası, 2004: 117-126 4-Arauz-Pacheco C, Ramirez LC, Pruneda L, et al. The effect of the aldose reductase inhibitor, ponalrestat, on the progression of diabetic retinopathy. J Diabetes Complications, 1992; 6: 131-137
• 5-Kim JW, Ai E, Diabetic retinopathy. In: Regillo CD, Brown GC, Flynn Jr HW (Eds), Vitreoretinal disease, the essentials, thieme; New York 1999; 133-159
• 6-Bresnick GH, Diabetic maculopathy a critical review highlighting diffuse macular edema. Ophthalmology 1983; 90: 1301-1317
• 7-Klein R, Klein BE, Moss SE, Visual impairment in diabetes. Ophthalmology 1984; 91: 1-9
• 8-Özçetin H, Optik koherens tomografi. 1. Baskı Ankara: Pozitif matbaacılık ve ambalaj sanayi ltd. şti. 2007: 3-21/79-91
• 9-Hikichi T, Fujio N, Akiba Y, et al. Association between the short-term natural history of diabetic macular edema and the vitreomacular relationship. Ophthalmology 1997;104:473–8
• 10-Hannouch RZ, De Avila MP, Isaac DLC, E Silva RSC,Rassi AR, Correlation between central subfield thickness, visual acuity and structural changes in diabetic macular edema. Arq Bras Oftalmol 2012; 75(3): 183-7
• 11-Alkuraya H, Kangave D, Abu El-Asrar AM, The correlation between optical coherence tomographic features and severity of retinopathy, macular thickness and visual acuity in diabetic macular edema. Int Ophthalmol 2005; 26: 93-99
• 12-Baskin DE, Optical coherence tomography in diabetic macular edema. Current opinion in ophthalmology 2010; 21: 172-177
• 13-Kim BY, Smith SD, Kaiser PK, Optical coherence tomographic patterns of diabetic macular edema. Am J Ophthalmol 2006; 142: 405-412
• 14- Yamamoto S, Yamamoto T, Hayashi M, Takeuchi S, Morphological and functional analyses of diabetic macular edema by optical coherence tomography and multifocal electroretinograms. Graefe’s Arch Clin Exp Ophthalmol 2001; 239: 96–101
• 15-Fine BS, Bruceker AJ, Macular edema and cystoid macular edema, Am J Ophthalmol 1981; 92: 466-481
• 16-Otani T, Kishi S, Maruyama Y, Patterns of diabetic macular edema with optical coherence tomography. Am J Ophthalmol 1999; 127: 688-693
• 17- Murakami T, Nıshıjıma K, Sakamoto A, Ota M, Horii T, Yoshimura N, Association of pathomorphology, photoreceptor status and retinal thickness with visual acuity in diabetic retinıphaty. Am J Ophthalmol 2011; 151(2); 310-7
• 18- Browning DJ, Glassman AR, Aiello LP et al. Relationship between optical coherence tomography measured central retinal thickness ana visual acuity in Diabetic macular edema. Ophthalmology 2007; 114(3): 525-536
• 19-Han IC, Jqaffe GJ, Evaluation of artifacts associated with macular spectral domain optical coherence tomography. Ophthalmology 2010; 117(6): 1177-89
• 20-DCCT Research Group, Progression of retinopathy with intensive versus convertional treatment in the Diabetes Control and Complications Trial. Ophthalmolpgy 1995; 102: 647-658 21-Macky TA, Mahgoub MM, The effect of glisemic Control on visual ana anotomic outcomes in response to therapy for Diabetic macular edema. Eur J Ophthalmol 2012; 23(1): 2-2